$210M Auction of Digital Monopolies — Teaser Catalog

Below are category highlights only. The full portfolio list (domains, marks, inclusions, reserves) is available to verified parties. Register free to preview, or request NDA access for the complete catalog.

Pre-offer deadline: Oct 10 • Live auction: Oct 15 — Greenwich, CT
📩 Register to Preview (Free) 🔒 Request NDA Access

Only one bidder will control each monopoly. Once they’re gone, they’re gone forever.

Healthcare

PatientFax™ (.com + .org)

HIPAA-ready patient data exchange & EHR interoperability standard.

  • Solves: fragmented record sharing, consent, auditability
  • Buyers: EHRs, hospital groups, payers, health IT

More healthcare assets in full catalog.

Insurance

InsuranceFraudRegistry.com + .org • FraudFax™

Reporting & compliance backbone against ~$300B annual fraud.

  • Solves: SIU intake, cross-carrier signals, regulator reporting
  • Buyers: national carriers, reinsurers, consortiums

NationalInsuranceFax.com + .org available via NDA.

Finance

MortgageFraudRegistry.com + .org

Authority brand for lender oversight, underwriting risk & AML/KYC signals.

  • Solves: fraud reporting, watchlists, secondary-market trust
  • Buyers: lenders, GSEs, mortgage tech, rating agencies
Real Estate

DeedFax™ (.com + .org) + NationalPropertyRegistry.com

Deed fraud prevention & property verification framework.

  • Solves: title risk, owner verification, transfer alerts
  • Buyers: title, escrow, county networks, lenders
AI Governance

AIComplianceRegistry.com (+ Global/National variants)

Anchor for AI policy, audit trails, & adoption signals across sectors.

  • Solves: model disclosures, vendor attestations, auditability
  • Buyers: cloud providers, AI platforms, regulators

Includes: GlobalAIComplianceRegistry.com/.org, NationalAIComplianceRegistry.com/.org.

Clinical / Pharma

NationalClinicalTrialsRegistry.com

Transparency & sponsor accountability for trials and pipelines.

  • Solves: disclosure gaps, trust, media referenceability
  • Buyers: pharma, CROs, regulators, investor media